Transduction is the process by which a noxious stimulus is converted into an electrical signal by the peripheral pain receptor. When a harmful stimulus activates a nociceptor, ion channels open and generate a receptor potential; if this reaches threshold, an action potential is produced and travels toward the spinal cord. This conversion is the first step in how pain starts at the site of injury. It is separate from conduction, which is simply the propagation of that electrical signal along the afferent nerve toward the spinal cord. It is also distinct from perception, which is the brain’s interpretation and conscious awareness of the pain, and from modulation, which involves endogenous mechanisms that increase or decrease the signal as it travels. For example, heat activating nociceptor channels and producing a receptor potential illustrates transduction at work.

Opioids cross the placenta mainly because of their lipid-loving, lipophilic nature, which allows them to diffuse readily across the placental membranes. Once in the fetal circulation, many opioids are weak bases, and the fetal environment is slightly more acidic than the maternal one. In this acidic setting, the drug tends to become protonated and charged, which limits its ability to cross membranes back out of the fetus. This results in ion trapping and accumulation of the drug in fetal tissues and fluids, increasing fetal exposure. Other options aren’t correct because placental transfer is not blocked by hormones, nor is it prevented by a lack of crossing; and while transporters exist, active pumping out isn’t the primary reason for entry or fetal accumulation.

Sodium thiopental primarily depresses respiration by acting on the brainstem respiratory center and blunting the ventilatory response to CO2. This leads to respiratory depression with a fall in tidal volume and respiratory rate, often accompanied by a brief period of apnea after a bolus. Minute ventilation drops and CO2 can rise until ventilation resumes or airway support is provided. It does not cause bronchodilation with tachypnea, nor does it increase tidal volume or leave respiration unchanged. Clinically, expect possible apnea after induction and be prepared to assist ventilation as the drug’s effects wane.

Meperidine is eliminated mainly by the kidneys, and its renal excretion is influenced by urine pH because it is a weak base. In acidic urine, the drug becomes more ionized and is less readily reabsorbed, leading to increased renal clearance. In alkaline urine, it remains more unionized and is reabsorbed more, reducing clearance. This is why the correct statement is that it is excreted primarily in urine with pH-dependent elimination. While it does undergo hepatic metabolism to normeperidine, the dominant route of elimination is renal, and the pH effect pertains to how urine acidity or alkalinity alters urinary excretion.

Propofol is an ultra-short-acting IV hypnotic. After a single bolus, the effect wears off in about 5–10 minutes because the drug rapidly redistributes from the brain to highly perfused tissues and is then cleared by the liver. This quick redistribution and clearance explain the brief duration of action, so recovery typically occurs within minutes after the dose. The other time ranges would only occur with much longer infusions or high cumulative doses, not with a single bolus. Note that while the onset to unconsciousness is rapid, the duration of a single dose remains in the 5–10 minute range.